November 6, 2019
Agreement with
March 1, 2020

Partnership with 2bind GmbH

We are delighted to announce our partnership with 2bind GmbH, based in Regensburg, Germany.

2bind offers innovative biophysical platforms for the in vitro validation of predicted hit compounds. This includes also compound handling, purchase, and management. Read more about the unique technology of Microscale Thermophoresis here. This multi-purpose biophysical assay system perfectly complements the in silico prediction of hits by our DiscoveryEngine to make your Drug Discovery project even more efficient. Contact us, if you want to know more.